Prevalence of HLA-B*5701 Allele in HIV-Infected Subjects in North America and Reductions in Risk for Development of Abacavir Associated Hypersensitivity Reaction

Conference Reports for NATAP

52nd ICAAC Interscience Conference on
Antimicrobial Agents and Chemotherapy
September 9-12, 2012, San Francisco


*Prevalence of HLA-B5701 Allele in HIV-Infected Subjects in North America and Reductions in Risk for Development of Abacavir Associated Hypersensitivity Reaction**

	Reported by Jules Levin 52nd ICAAC Sept 9-12 2012 SF CB Small,1D Wohl,2DA Margolis,3B Wine,3LL Ross,3H Zhao,3MS Shaefer4 1New York Medical College, Valhalla, NY, United States; 2AIDS Clinical Trials Unit, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States; 3GlaxoSmithKline, Research Triangle Park, NC, United States; 4ViiV Healthcare, Research Triangle Park, NC, United States